| Announce Date | 02/19/2025 |
| EPS Normalized Actual | $-0.18 (Miss by $-0.04) |
| EPS GAAP Actual | $-0.18 (Miss by $-0.04) |
| Revenue Actual | $0.035516B |
| Revenue Surprise | Beat by $35.516M |
| Announce Date | 01/05/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.13 |
| EPS GAAP Estimate | $-0.13 |
| Revenue Estimate | $0.04076B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Apr 2028 | 0 | INF | 0 | 0 | 1 |
| Apr 2028 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2025 (Jan 2025) | -0.19 | -0.19 | 0.035516B | 100% | 35.52M |
| FQ4 2024 (Oct 2024) | -0.22 | -0.22 | 0.026482B | 100% | 26.48M |
| FQ3 2024 (Jul 2024) | -0.0002 | -0.0002 | 0.030595B | 100% | 30.6M |
| FQ2 2021 (Jun 2021) | -0.0001 | -0.0001 | 0B | NAN% | 0M |
| FQ4 2021 (Dec 2021) | -0.0003 | -0.0003 | 0B | NAN% | 0M |
| FQ1 2022 (Mar 2022) | 0.3 | 0.3 | 0B | NAN% | 0M |
| FQ2 2024 (Apr 2024) | -0.22 | -0.22 | 0.036198B | 20.58% | 36.2M |
| FQ3 2022 (Jul 2022) | 0.0462 | 0.0462 | 0.0244625B | 100% | 24.46M |
FQ4 Announce Date
01/05/2026 (Pre-Market)
Consensus EPS Estimates
-0.13
Consensus Revenue Estimates
0.04076B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2026 (Apr 2026) | -0.19 | -- | -0.19992 | -0.18008 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2026 (Apr 2026) | 0.05B | -- | 0.05B | 0.05B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
0
Revenue # of in-lines
3
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Jan 2025) | -0.19 | -0.19 | 100% | |
| FQ4 2024 (Oct 2024) | -0.22 | -0.22 | 100% | |
| FQ3 2024 (Jul 2024) | -0.0002 | -0.0002 | 100% | |
| FQ2 2021 (Jun 2021) | -0.0001 | -0.0001 | 100% | |
| FQ4 2021 (Dec 2021) | -0.0003 | -0.0003 | 100% | |
| FQ1 2022 (Mar 2022) | 0.3 | 0.3 | 100% | |
| FQ2 2024 (Apr 2024) | -0.22 | -0.22 | 100% | |
| FQ3 2022 (Jul 2022) | 0.0462 | 0.0462 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Jan 2025) | $0B | $0.04B | $35.52M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0.03B | $26.48M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.03B | $30.6M | 100% |
| FQ2 2021 (Jun 2021) | $0B | $0B | $0M | NAN% |
| FQ4 2021 (Dec 2021) | $0B | $0B | $0M | NAN% |
| FQ1 2022 (Mar 2022) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Apr 2024) | $0B | $0.04B | $36.2M | 100% |
| FQ3 2022 (Jul 2022) | $0B | $0.02B | $24.46M | 100% |